Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hypertonic saline versus Ringer lactate for intraoperative fluid management in major uro-oncologic surgery
IRCT20150116020676N3Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of hypertonic saline and lactated ringer's solution in cancer (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Hemodynamic conditions, Electrolytes and 1 more. Started Jan 2019; status: completed.
02
Drugs
hypertonic salinelactated ringer's solution
03
Conditions
cancer
Beyond the preview
Go deeper on IRCT20150116020676N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150116020676N3.